Viewing Study NCT02846506


Ignite Creation Date: 2025-12-26 @ 5:17 PM
Ignite Modification Date: 2026-01-22 @ 7:30 AM
Study NCT ID: NCT02846506
Status: COMPLETED
Last Update Posted: 2025-02-03
First Post: 2016-07-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Bioequivalence of the Metformin Component of the Fixed Dose Combination Tablet of Canagliflozin and Metformin Extended Release With Respect to Metformin XR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted Participants
Sponsor: Janssen Research & Development, LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module